$20.97
-0.12 (-0.57%)
Performance
1D
—
1W
—
1M
—
3M
+24.30%
6M
+50.32%
1Y
+48.51%
YTD
+28.89%
Open$20.73
Previous Close$21.09
Day High$21.21
Day Low$20.54
52W High$23.77
52W Low$10.57
Volume—
Avg Volume1.48M
Market Cap3.20B
P/E Ratio—
EPS$-2.97
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$18.67
Above
SMA 200
$15.96
Above
RSI (14)
42.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
+265.0% upside
Current
$20.97
$20.97
Target
$76.55
$76.55
$56.04
$76.55 avg
$105.76
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 267.02M | 243.47M | 233.58M |
| Net Income | 59.27M | 48.26M | 42.10M |
| Profit Margin | 22.2% | 19.8% | 18.0% |
| EBITDA | 80.54M | 76.00M | 71.04M |
| Free Cash Flow | 42.58M | 43.55M | 31.33M |
| Rev Growth | -5.4% | -1.1% | +3.4% |
| Debt/Equity | 0.51 | 0.57 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |